Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2008
11/26/2008CN100435656C Fruit and/or vegetable derived composition
11/26/2008CN100435645C Anti-radiation tea
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2370565C Dermally applicable vitamin d-containing pharmaceutical compositions
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/20/2008WO2008140026A1 Novel leukotriene receptor antagonist
11/20/2008WO2008139754A1 2,6-di-tert-butylphenol derivative and melanogenesis inhibitor comprising 2,6-di-tert-butylphenol derivative as the active ingredient
11/20/2008WO2008139487A1 Homeopathy-based formulation
11/20/2008WO2008139182A2 Skin care composition
11/20/2008WO2008139124A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008WO2008139123A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008WO2008139122A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008WO2008138968A2 Dosage form comprising 10-[(3s)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine, provided in a form suitable for oral administration of a daily dose of 1 mg to 3 mg
11/20/2008WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
11/20/2008WO2008138939A1 Pyrazolone derivatives as pde4 inhibitors
11/20/2008WO2008138839A2 Preparation of cosmetic active principles by culturing vitreoscilla on thermal water and compositions comprising them
11/20/2008WO2008138524A1 Use of biotin to prevent photoaging
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008096203A3 Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
11/20/2008WO2008065408A3 Modulation of prostaglandin/cyclooxygenase metabolic pathways
11/20/2008US20080287552 Process for Obtaining an Active Ingredient for Enhancing Cutaneous Mechanical Strength, Active Ingredient and Compositions
11/20/2008US20080287536 Topical applying; acne; alopecia
11/20/2008US20080287528 Therapeutic methods and compositions involving isoflavones
11/20/2008US20080287520 Use of Melatonin in Preventing Postoperative Complications
11/20/2008US20080287513 Topical compositions containing metronidazole
11/20/2008US20080287507 Nicotine containing toiletry waters
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080287477 Novel Compounds as Modulators of Ppar
11/20/2008US20080287468 Purine and imidazopyridine derivatives for immunosuppression
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287459 Pharmaceutical Composition for Treating Hair Loss and Benign Prostatic Hyperplasia
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287442 Organic Compounds
11/20/2008US20080287402 Use of a glial attenuator to prevent amplified pain responses caused by glial priming
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
11/20/2008US20080287393 External Skin Composition
11/20/2008US20080287392 Wound-Healing Pharmaceutical Compositions in the Form of a Cream Based on Amino Acids and Sodium Hyaluronate
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287377 Composition Based on Triethyl Citrate for the Prevention of Enzymatic Hydrolysis of Triglycerides
11/20/2008US20080287373 Topical skin treating kits
11/20/2008US20080286384 Topical Wound Care Product Containing Hyssop
11/20/2008US20080286356 Pharmaceutical compositions containing terbinafin and use thereof
11/20/2008US20080286346 Wound Dressing
11/20/2008US20080286329 Blood-derived plastic bone tissue articles; Young's Modulus of 0.03 GPa to 50 GPa; article; biological response modifiers hormones, growth factors, cytokines, extracellular matrix molecules; crosslinking agents iridoid derivatives, diimidates, diones; plasticizers phthalate, adipate, plant oils, glycols
11/20/2008US20080286299 Film-forming resins as a carrier for topical application of pharmacologically active agents
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286261 Methods of modulating hair growth
11/20/2008US20080286243 Method For Isolation of a Hair Follicle Stem Cell and a Composition For Hair Reproduction
11/20/2008US20080286229 Method to promote hair growth and/or delay or treat hair loss by administering a tgf-beta antagonist or inhibitor
11/20/2008US20080286220 Hair Treatment Compositions Comprising A Disaccharide, A Di-Acid And A Source Of Ammonium Ions
11/20/2008US20080286217 Sunscreen compositions and methods
11/20/2008US20080286212 Antimicrobial Formulations and Methods of Using the Same
11/20/2008CA2686909A1 Pyrazolone derivatives as pde4 inhibitors
11/20/2008CA2686511A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008CA2686505A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/19/2008EP1992645A1 Novel low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition and food composition each using same
11/19/2008EP1992644A1 Antibodies against CCR4 and its fragments
11/19/2008EP1992642A1 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1992622A1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
11/19/2008EP1992344A1 P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
11/19/2008EP1991673A2 Method and apparatus for acne treatment using low intensity light therapy
11/19/2008EP1991548A1 Salt of cd 80 antagonist
11/19/2008EP1991538A1 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
11/19/2008EP1991222A1 Melatonin and immunostimulating substance-based compositions
11/19/2008EP1736157B1 Morphinan derivatives as anti-itching agent
11/19/2008EP1680413B1 NEW RAR-beta RECEPTOR-ACTIVATING LIGAND, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008EP1441685B1 Compositions for anti-irritating rosacea treatment
11/19/2008EP1392369B1 Use of sheets for producing body compresses and a pre-product and device therefor
11/19/2008EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/19/2008EP1320357B1 Topical polymeric antimicrobial emulsion
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008CN101309932A Novel mucin glycoprotein and use thereof
11/19/2008CN101309912A Oxazole compound and pharmaceutical composition
11/19/2008CN101309746A Method for production of single- and multi-layer microcapsules
11/19/2008CN101309669A Compositions of lipoxygenase inhibitors
11/19/2008CN101309596A Compositions and methods for improving skin health and pelage quality
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306193A Use of neuritis auxin in preparing wound healing medicine
11/19/2008CN101306189A Traditional Chinese medicine capsule for preventing and curing alopecia
11/19/2008CN101306187A Topical paste for treating burns and its production method
11/19/2008CN101306186A Traditional Chinese medicine taken orally for treating Qi stagnation and blood stasis type zoster
11/19/2008CN101306175A Medicine for treating whelk, comedo and acne
11/19/2008CN101306168A Traditional Chinese medicine taken orally for treating dry seborrheic dermatitis
11/19/2008CN101306163A Zhixue shengji powder
11/19/2008CN101306151A Traditional Chinese drug composition for treating injuries from falls
11/19/2008CN101306148A Traditional Chinese medicine orally taken for treating intractable psoriasis
11/19/2008CN101306142A Yangxuemeiyan capsule
11/19/2008CN101306141A Decoction for treating qi-blood disharmony type vitiligo
11/19/2008CN101306127A Chinese traditional medicine orally taken for treating cystic acne
11/19/2008CN101306126A Quality control method of compound south isatis root granules
11/19/2008CN101306117A Production of Qufu powder and Shengjizhangpi paste and evodia fruit paste